Vitamin analogues in chemoprevention of hepatocellular carcinoma after resection or ablation-a systematic review and meta-analysis

Asian Journal of Surgery

Volumn 33, Issue 3, 2010, Pages 120-126

  Chu, Kai Jian ^a   Lai, Eric C H ^a,b   Yao, Xiao Ping ^a   Zhang, Hong Wei ^a   Lau, Wan Yee ^a,b   Fu, Xiao Hui ^a   Lu, Chong De ^a   Shi, Jie ^a   Cheng, Shu Qun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Chinese University of Hong Kong   (Hong Kong)

Author keywords

Chemoprevention; Hepatectomy; Hepatocellular carcinoma; Vitamin A; Vitamin K

Indexed keywords

VITAMIN;

ABLATION THERAPY; ADJUVANT CHEMOTHERAPY; ARTICLE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; META ANALYSIS;

ABLATION TECHNIQUES; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; VITAMINS;

EID: 78650350171     PISSN: 10159584     EISSN: 02193108     Source Type: Journal    
DOI: 10.1016/S1015-9584(10)60021-8     Document Type: Article

References (31)

1. HB El-Serag, KL Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
2. EC Lai, WY Lau The continuing challenge of hepatic cancer in Asia Surgeon 3 2005 210 215
3. WY Lau, EC Lai Hepatocellular carcinoma: current management and recent advances Hepatobiliary Pancreat Dis Int 7 2008 237 257
4. CH Zhang, GL Xu, WD Jia Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials Int J Cancer 124 2009 2982 2988
5. EC Lai, WY Lau, DV Mann Selection of patients for liver resection WY Lau Hepatocellular Carcinoma 2008 World Scientific Publishing Singapore 303 316
6. rd edition Surgery of the Liver and Biliary Tract Volume II 2000 WB Saunders London 1423 1450
7. WY Lau, EC Lai Neoadjuvant/adjuvant/chemoprevention therapy and tumor downstaging WY Lau Hepatocellular Carcinoma 2008 World Scientific Publishing Singapore 709 738
8. ES Chan, PK Chow, B Tai Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma Cochrane Database Syst Rev 2000 CD001199.
9. JD Schwartz, M Schwartz, J Mandeli Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials Lancet Oncol 3 2002 593 603
10. M Colombo, MF Donato Prevention of hepatocellular carcinoma Semin Liver Dis 25 2005 155 161
11. T Kuzuya, Y Katano, T Kumada Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma J Gastroenterol Hepatol 22 2007 1929 1935
12. Y Muto, H Moriwaki, M Ninomiya Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group N Engl J Med 334 1996 1561 1567 (Pubitemid 26177483)
13. 2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study Cancer 106 2006 867 872
14. JL Fleiss, AJ Gross Meta analyses in epidemiology, with special reference to studies of association between exposure to environmental tobacco smoke and lung cancer: a critique J Clin Epidemiol 44 1991 127 139
15. K Takai, M Okuno, I Yasuda Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data Intervirology 48 2005 39 45
16. S Kakizaki, N Sohara, K Sato Preventive effects of vitamin K on recurrent disease in patients with hepatocellular carcinoma arising from hepatitis C viral infection J Gastroenterol Hepatol 22 2007 518 522
17. 2 on the recurrence in patients with hepatocellular carcinoma Hepatogastroenterology 54 2007 2073 2077
18. 2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma J Hepatol 51 2009 315 321
19. WY Lau, EC Lai, SH Lau The current role of neoadjuvant/adjuvant/ chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review Hepatobiliary Pancreat Dis Int 8 2009 124 133
20. PA Clavien Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection? Ann Surg 245 2007 843 845
21. M Shi, RP Guo, XJ Lin Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial Ann Surg 245 2007 36 43
22. IH Wong, W Yeo, T Leung Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation Cancer Lett 167 2001 183 191
23. IH Wong, WY Lau, T Leung Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepa-tocellular carcinoma: a quantitative analysis Clin Cancer Res 5 1999 4021 4027
24. IH Wong, T Leung, S Ho Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction Br J Cancer 76 1997 628 633
25. 2 in leukemia cells Leukemia 15 2001 1111 1117 (Pubitemid 32717282)
26. Y Nishikawa, BI Carr, M Wang Growth inhibition of hepatoma cells induced by vitamin K and its analogs J Biol Chem 270 1995 28304 28310
27. M Shimizu, K Takai, H Moriwaki Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention Cancer Sci 100 2009 369 374
28. H Moriwaki, I Yasuda, Y Shiratori Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma Clin Cancer Res 3 1997 727 731
29. S Kojima, M Okuno, R Matsushima-Nishiwaki Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review) Int J Oncol 24 2004 797 805
30. 2 and enhancement by MEK inhibition Int J Oncol 29 2006 1501 1508
31. 2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation Clin Cancer Res 13 2007 2236 2245